Tradestie Institutional Equity Comparison Engine

RIGL vs DMAC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

RIGL Overall Edge

RIGL Captures Institutional Edge (3โ€“1 Pillars ยท 10โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Rigel Pharmaceuticals Inc. (New) (RIGL) driven by superior Valuation, Growth & Margin, Options & Structure while DMAC counters with relative strength in Momentum & Technical. Fundamentally, RIGL trades at 9.3x Forward P/E with 26.3% operating margin (+16.5% YoY revenue) versus DMAC at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, RIGL sits in CONSOLIDATION (4th %ile IV; Dealer Gamma Walls on Pro) against DMAC sits in SURGE (14th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner RIGL
RIGL 9.3x vs DMAC N/M Fwd P/E
Growth & Margin Winner RIGL
Op Margin 26.3% vs 0.0% ยท YoY +16.5% vs +0.0%
Momentum & Technical Winner DMAC
1Y +9.7% vs +55.3% ยท 52W Pos 68% vs 55%
Options & Structure Winner RIGL
CONSOLIDATION (4th %ile IV) vs SURGE (14th %ile IV)
RIGL NASDAQ
Rigel Pharmaceuticals Inc. (New)
Pharmaceutical Preparations
$43.73
-1.64% 1D
Market Cap $860.3M
1M Return -4.87%
1Y Return +9.65%
Forward P/E 9.3x
Unified AI Score
59.9 / 100 HOLD
Tech 48.0 Fund 58.0 Flow 68.0 Mom 60.0
DMAC NASDAQ
DiaMedica Therapeutics Inc. Common Stock
Pharmaceutical Preparations
$8.41
-4.27% 1D
Market Cap $503.1M
1M Return +11.16%
1Y Return +55.26%
Forward P/E N/M
Unified AI Score
46.3 / 100 HOLD
Tech 30.0 Fund 51.0 Flow 65.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RIGL +9.65% DMAC +55.26% Spread: +45.61 pp (DMAC Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period RIGL Revenue DMAC Revenue RIGL Op. Margin DMAC Op. Margin Margin Edge
FY2018 $40M $0M -163.3% -1352.2% RIGL
FY2019 $60M N/A -116.5% N/A RIGL
FY2020 $110M N/A -26.7% N/A RIGL
FY2021 $150M N/A -8.4% N/A RIGL
FY2022 $120M N/A -46.2% N/A RIGL
FY2023 $120M N/A -17.5% N/A RIGL
FY2024 $180M N/A 13.5% N/A RIGL
FY2025 $290M N/A 42.6% N/A RIGL

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RIGL (10) vs DMAC (0)
Institutional Metric RIGL DMAC Criterion Row Winner
Market Capitalization Scale $860.3M $503.1M Larger Scale RIGL
Trailing P/E Ratio Valuation 2.8x N/M Lower Multiple RIGL
Forward P/E Ratio Valuation 9.3x N/M Lower Multiple RIGL
Revenue Growth (YoY) Growth +16.5% +0.0% Higher Growth RIGL
Operating Margin (TTM) Profitability 26.3% 0.0% Higher Margin RIGL
Net Profit Margin Profitability 106.6% 0.0% Higher Margin RIGL
Return on Equity (ROE) Capital Efficiency 109.2% -114.6% Higher ROE RIGL
52-Week Range Position Momentum 68% ($25โ€“$53) 55% ($5โ€“$11) Stronger Trend RIGL
Beta / 30D Volatility Risk Regime 1.05ฮฒ ยท 74% Vol 1.74ฮฒ ยท 98% Vol Lower Realized Risk RIGL
Unified Institutional Score Composite Signal 59.9 / 100 (HOLD) 46.3 / 100 (HOLD) Higher Composite RIGL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RIGL vs DMAC Buy Guide
RIGL CONSOLIDATION
91d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 4th %ile
IV Regime Compressed (<25th %ile)
Live RIGL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DMAC SURGE
8d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 14th %ile
IV Regime Compressed (<25th %ile)
Live DMAC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RIGL nor DMAC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.